Sino Biopharmaceutical Investor Relations Material

Sino Biopharmaceutical Limited is a Chinese pharmaceutical company focused on the research, development, manufacturing, and distribution of a wide range of pharmaceutical products. The company’s portfolio covers therapeutic areas such as oncology, hepatitis, cardiovascular, orthopedics, and respiratory diseases. Sino Biopharmaceutical emphasizes innovation through its research and development efforts, producing both innovative and generic drugs to meet healthcare needs in China and internationally. The company is headquartered in Beijing, China, and its shares are listed on the Hong Kong Stock Exchange.